Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Nitrendipine

A dihydropyridine calcium channel blocker that relaxes blood vessel walls, used for high blood pressure: patented in 1971 and approved for medical use in 1985. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?It was the first-line drug of the European Syst-Eur trial, which in the 1990s showed that treating isolated systolic hypertension in older people reduces cardiovascular complications.

NitrendipineGo to the active ingredient →
NitrendipineActive ingredientNitrendipineCat. No. P-N078-001CAS 39562-70-4

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.